Rabbit Anti-Human VEGFR-3/FLT-4
Slide this table
| Cat-Nr. | 102-PA22AG |
| Size | 50 µg |
| Price | 185 € |
| Category | Polyclonal Antibody |
| Clone Nr. | Rabbit IgG |
| Species Reactivity | Human |
| Formulation | lyophilized |
| Buffer | PBS |
| Reconstitution | Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml. |
| Stability and Storage | The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots. |
| Preparation | Produced from sera of rabbits immunized with highly pure recombinant human soluble VEGFR 3/FLT-4 (D1-D7). Anti-human VEGFR-3/FLT-4 was purified by antigen-affinity chromatography with immobilized soluble VEGFR-3/FLT-4. |
| Antigen | Recombinant human sFLT-4 (D1-7) (RT #S01-017) |
| Application | WB, IP, E, IHC (C) |
| Synonyms | vascular endothelial growth factor receptor-3; FLT4; PCL; LMPH1A; VEGFR3; fms-related tyrosine kinase 4 |
| Description | Receptor tyrosine Kinase VEGFR-3, also known as FLT4, together with VEGFR1 (FIT1) and VEGFR2 (KDR/Flk-1), are the receptors for vascular endothelial growth factors (VEGF). The VEGFR family belongs to the class II subfamily of receptor tyrosine kinases (RTKs), containing a large extracellular region which is composed of seven Ig-like domains (D1–D7), a single transmembrane (TM) helix and cytoplasmic region with a tyrosine kinase activity. In VEGFR-3, the fifth Ig homology domain is proteolytically cleaved which results in polypeptides remain linked by two disulfide bonds. VEGFR-3 is widely expressed on all endothelia cells in early embryogenesis, while, in adult tissues, VEGFR-3 expression disappears from the vascular endothelial cells and is observed only on the lymphatic endothelium. VEGF-C and VEGF-D activation of VEGFR-3 plays an important role in the formation of the lymphatic vessel system. |
| Uniprot ID | P35916 |
| Protein RefSeq | NP_002011 |
| mRNA RefSeq | NM_002020 |
Figures
Immunofluorescence staining (green) of VEGFR-3/FLT4 in primary human dermal lymphatic endothelial cells (HDLEC) with anti-human VEGFR-3/FLT4 (10μg/ml) [Cat# 102-PA22AG] and counter staining of nuclei with Dapi. As secondary antibody goat anti-rabbit ALEXA Flour 488 (Dianova) was used 1:800.
Western Analysis of anti-human VEGFR-3/FLT-4. Samples were loaded in 7.5% SDS-polyacrylamide gel under reducing conditions.
FACS analysis with primary human dermal lymphatic endothelial cells (HDLEC).
Reference
- CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1. C. Reger de Moura et al., Cancers (Basel). 2021 Oct; 13(19): 4859.
- Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis. S. C. Johns et al., Circ Res. 2016 Jul 8; 119(2): 210–221.
- Lymphatic Endothelial Heparan Sulfate Deficiency Results in Altered Growth Responses to Vascular Endothelial Growth Factor-C (VEGF-C). X. Yin et al., J Biol Chem. 2011 Apr 29; 286(17): 14952–14962.
All prices plus VAT + possible delivery charges